Kodiak Sciences Announces Fourth Quarter and Full Year 2022

/PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative...

Related Keywords

Visp , Switzerland General , Switzerland , Victor Perlroth , Exchange Commission , Prnewswire Kodiak Sciences Inc , Securities Exchange , Kodiak Sciences Inc , Digital Health Platform Development , Nasdaq , Technology Platform Development , Kodiak Sciences , Chief Executive Officer , Investigational New Drug , Platform Development , Health Platform Development , Full Year , Antibody Biopolymer Conjugate , Trial Identifiers , Trial Identifier , Palo Alto , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Consolidated Statements , Consolidated Balance Sheet Data ,